» Articles » PMID: 37242805

Differential Expression of Transporter Genes in Brain Vessels Vs. Peripheral Tissues and Vessels from Human, Mouse and Rat

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2023 May 27
PMID 37242805
Authors
Affiliations
Soon will be listed here.
Abstract

Background: ATP-binding cassette (ABC) transporters comprise a superfamily of genes encoding membrane proteins with nucleotide-binding domains (NBD). These transporters, including drug efflux across the blood-brain barrier (BBB), carry a variety of substrates through plasma membranes against substrate gradients, fueled by hydrolyzing ATP. The expression patterns/enrichment of transporter genes in brain microvessels compared to peripheral vessels and tissues are largely uncharacterized.

Methods: In this study, the expression patterns of transporter genes in brain microvessels, peripheral tissues (lung, liver and spleen) and lung vessels were investigated using RNA-seq and Wes analyses in three species: human, mouse and rat.

Results: The study demonstrated that drug efflux transporter genes (including , , and ) were highly expressed in isolated brain microvessels in all three species studied; the expression of , , , and was generally higher in rodent brain microvessels compared to those of humans. In contrast, and expression was low in brain microvessels, but high in rodent liver and lung vessels. Overall, most transporters (with the exception of drug efflux transporters) were enriched in peripheral tissues compared to brain microvessels in humans, while in rodent species, additional transporters were found to be enriched in brain microvessels.

Conclusions: This study furthers the understanding of species similarities and differences in the expression patterns of transporter genes; this is important for translational studies in drug development. In particular, CNS drug delivery and toxicity may vary among species depending on their unique profiles of transporter expression in brain microvessels and BBB.

Citing Articles

Role of ABCC5 in cancer drug resistance and its potential as a therapeutic target.

Pan Y, Wu M, Cai H Front Cell Dev Biol. 2024; 12:1446418.

PMID: 39563862 PMC: 11573773. DOI: 10.3389/fcell.2024.1446418.


The impact of ATP-binding cassette transporters in the diseased brain: Context matters.

Baltira C, Aronica E, Elmquist W, Langer O, Loscher W, Sarkaria J Cell Rep Med. 2024; 5(6):101609.

PMID: 38897176 PMC: 11228798. DOI: 10.1016/j.xcrm.2024.101609.


Circadian Rhythms of the Blood-Brain Barrier and Drug Delivery.

Kim M, Keep R, Zhang S Circ Res. 2024; 134(6):727-747.

PMID: 38484027 PMC: 11584049. DOI: 10.1161/CIRCRESAHA.123.323521.


Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders.

Zhang W Handb Exp Pharmacol. 2023; 284:213-230.

PMID: 37528323 DOI: 10.1007/164_2023_689.

References
1.
Dean M, Rzhetsky A, Allikmets R . The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 2001; 11(7):1156-66. DOI: 10.1101/gr.184901. View

2.
Atkins J, George G, Hess K, Marcelo-Lewis K, Yuan Y, Borthakur G . Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials. Br J Cancer. 2020; 123(10):1496-1501. PMC: 7652903. DOI: 10.1038/s41416-020-01033-x. View

3.
Bamji-Mirza M, Li Y, Najem D, Liu Q, Walker D, Lue L . Genetic Variations in ABCA7 Can Increase Secreted Levels of Amyloid-β40 and Amyloid-β42 Peptides and ABCA7 Transcription in Cell Culture Models. J Alzheimers Dis. 2016; 53(3):875-92. DOI: 10.3233/JAD-150965. View

4.
Shen S, Zhang W . ABC transporters and drug efflux at the blood-brain barrier. Rev Neurosci. 2010; 21(1):29-53. DOI: 10.1515/revneuro.2010.21.1.29. View

5.
Zhang W, Mojsilovic-Petrovic J, Andrade M, Zhang H, Ball M, Stanimirovic D . The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J. 2003; 17(14):2085-7. DOI: 10.1096/fj.02-1131fje. View